C Schüttler1, N Buschhüter2, C Döllinger3, L Ebert4, M Hummel5, J Linde6, H-U Prokosch7, R Proynova4, M Lablans4. 1. Lehrstuhl für Medizinische Informatik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Wetterkreuz 13, 91058, Erlangen, Deutschland. christina.schuettler@fau.de. 2. Zentralisierte Biomaterialbank der Medizinischen Fakultät der RWTH Aachen University, Aachen, Deutschland. 3. BioMaterialBank Heidelberg, Universitätsklinikum Heidelberg, Heidelberg, Deutschland. 4. Medizinische Informatik in der Translationalen Onkologie, Deutsches Krebsforschungszentrum, Heidelberg, Deutschland. 5. Zentrale Biomaterialbank (ZeBanC) und German Biobank Node (GBN), Charité-Universitätsmedizin Berlin, Berlin, Deutschland. 6. UMG Biobank, Universitätsmedizin Göttingen, Göttingen, Deutschland. 7. Lehrstuhl für Medizinische Informatik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Wetterkreuz 13, 91058, Erlangen, Deutschland.
Abstract
BACKGROUND: The large number of biobanks within Germany results in a high degree of heterogeneity with regard to the IT components used at the respective locations. Within the German Biobank Alliance (GBA), 13 biobanks implement harmonized processes for the provision of biomaterial and accompanying data. OBJECTIVES: The networking of the individual biobanks and the associated harmonisation of the IT infrastructure should facilitate access to biomaterial and related clinical data. METHODS: For this purpose, the relevant target groups were first identified in order to determine their requirements for IT solutions to be developed in a workshop. RESULTS: Of the seven identified interest groups, three were initially invited to a first round of discussions. The stakeholder input expressed resulted in a catalogue of requirements with regard to IT support for (i) a sample and data request, (ii) the handling of patient consent and inclusion, and (iii) the subsequent evaluation of the sample and data request. CONCLUSIONS: The next step is to design the IT solutions as prototypes based on these requirements. In parallel, further user groups are being surveyed in order to be able to further concretise the specifications for development.
BACKGROUND: The large number of biobanks within Germany results in a high degree of heterogeneity with regard to the IT components used at the respective locations. Within the German Biobank Alliance (GBA), 13 biobanks implement harmonized processes for the provision of biomaterial and accompanying data. OBJECTIVES: The networking of the individual biobanks and the associated harmonisation of the IT infrastructure should facilitate access to biomaterial and related clinical data. METHODS: For this purpose, the relevant target groups were first identified in order to determine their requirements for IT solutions to be developed in a workshop. RESULTS: Of the seven identified interest groups, three were initially invited to a first round of discussions. The stakeholder input expressed resulted in a catalogue of requirements with regard to IT support for (i) a sample and data request, (ii) the handling of patient consent and inclusion, and (iii) the subsequent evaluation of the sample and data request. CONCLUSIONS: The next step is to design the IT solutions as prototypes based on these requirements. In parallel, further user groups are being surveyed in order to be able to further concretise the specifications for development.
Authors: H U Prokosch; A Beck; T Ganslandt; M Hummel; M Kiehntopf; U Sax; F Uckert; S Semler Journal: Appl Clin Inform Date: 2010-11-24 Impact factor: 2.342
Authors: Sebastian Mate; Dennis Kadioglu; Raphael W Majeed; Mark R Stöhr; Michael Folz; Patric Vormstein; Holger Storf; Daniel P Brucker; Dietmar Keune; Norman Zerbe; Michael Hummel; Karsten Senghas; Hans-Ulrich Prokosch; Martin Lablans Journal: Stud Health Technol Inform Date: 2017
Authors: Rumyana Proynova; Diogo Alexandre; Martin Lablans; David Van Enckevort; Sebastian Mate; Niina Eklund; Kaisa Silander; Michael Hummel; Petr Holub; Frank Ückert Journal: Stud Health Technol Inform Date: 2017
Authors: Christina Schüttler; Verena Huth; Magdaléna von Jagwitz-Biegnitz; Martin Lablans; Hans-Ulrich Prokosch; Lena Griebel Journal: J Med Internet Res Date: 2020-08-18 Impact factor: 5.428
Authors: Sebastian Mate; Marvin Kampf; Wolfgang Rödle; Stefan Kraus; Rumyana Proynova; Kaisa Silander; Lars Ebert; Martin Lablans; Christina Schüttler; Christian Knell; Niina Eklund; Michael Hummel; Petr Holub; Hans-Ulrich Prokosch Journal: Appl Clin Inform Date: 2019-09-11 Impact factor: 2.342